Reaction

Patella Fracture reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,299 reports · 36 co-occurring drugs

As of the last recalculation, Patella Fracture appears in 2,299 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 17.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alendronate Sodium	176	17.0	17.0
Emtricitabine And Tenofovir Alafenamide	18	14.5	14.5
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	12	10.9	10.9
Teriparatide	124	10.5	10.5
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	10	10.1	10.1
Raloxifene Hydrochloride	14	8.7	8.7
Romosozumab-Aqqg	13	8.7	8.7
Tizanidine Hydrochloride	17	8.6	8.6
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	17	8.5	8.6
Emtricitabine And Tenofovir Disoproxil Fumarate	42	8.5	8.5
Pitavastatin Calcium	8	7.1	7.1
Tolterodine Tartrate	7	7.1	7.1
Fexofenadine Hcl	7	6.9	6.9
Lopinavir And Ritonavir	10	6.7	6.7
Tenofovir Disoproxil Fumarate	23	6.4	6.4
Dolutegravir Sodium	6	6.0	6.0
Dorzolamide Hydrochloride And Timolol Maleate	5	5.7	5.7
Benzonatate	10	5.5	5.5
Risankizumab-Rzaa	42	4.7	4.7
Lanreotide Acetate	4	4.6	4.6
Upadacitinib	41	4.6	4.6
Asfotase Alfa	5	4.5	4.5
Denosumab	96	4.4	4.4
Peginterferon Beta-1A	6	4.2	4.2
Interferon Beta-1A	71	3.4	3.4
Abaloparatide	11	3.4	3.4
Sodium Oxybate	23	3.2	3.2
Encorafenib	3	2.7	2.7
Benralizumab	6	2.7	2.7
Dalfampridine	21	2.7	2.7
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	9	2.6	2.6
Dimethyl Fumarate	31	2.3	2.3
Diroximel Fumarate	3	2.3	2.3
Valbenazine	6	2.2	2.2
Patiromer	3	2.0	2.0
Pimavanserin Tartrate	6	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.